In vivo enrichment of diabetogenic T cells

23Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Dysfunctional T cells can mediate autoimmunity, but the inaccessibility of autoimmune tissues and the rarity of autoimmune T cells in the blood hinder their study. We describe a method to enrich and harvest autoimmune T cells in vivo by using a biomaterial scaffold loaded with protein antigens. In model antigen systems, we found that antigen-specific T cells become enriched within scaffolds containing their cognate antigens. When scaffolds containing lysates from an insulin-producingβ-cellline were implanted subcutaneously in autoimmune diabetes-prone NOD mice, b-cell-reactive T cells homed to these scaffolds and became enriched. These T cells induced diabetes after adoptive transfer, indicating their pathogenicity. Furthermore, T-cell receptor (TCR) sequencing identified many expanded TCRs within theβ-cellscaffolds that were also expanded within the pancreata of NOD mice. These data demonstrate the utility of biomaterial scaffolds loaded with disease-specific antigens to identify and study rare, therapeutically important T cells.

Cite

CITATION STYLE

APA

Thelin, M. A., Kissler, S., Vigneault, F., Watters, A. L., White, D., Koshy, S. T., … Ali, O. A. (2017). In vivo enrichment of diabetogenic T cells. Diabetes, 66(8), 2220–2229. https://doi.org/10.2337/db16-0946

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free